Concepedia

Author

Benjamin Brady

The University of Sydney

Also Known As

B Brady, B. Brady, Benjamin Brady, Benjamin M Brady, Benjamin M. Brady, Benjamin M. R. Brady, Benjamin M.R Brady, Benjamin M.R. Brady, Benjamin MR Brady, Bridgitte Brady

31

Publications

6.9K

Citations

14

H-Index

29

Concepts

All Affiliations

The University of SydneyMelanoma Institute AustraliaCabrini HospitalUniversité Paris CitéBristol-Myers Squibb (United States)
BB

About

Benjamin Brady is an author at The University of Sydney specializing in medicine, dermatology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

766

2

Immunology

3

3

723

3

Allergy

1

1

91

4

Communication

1

1

15

5

Computer Science

1

1

15

Benjamin Brady

×

15

Publications

6.9K

Citations

13

H-Index

YearCitations

Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation

Caroline Robert, Georgina V. Long, Benjamin Brady,

New England Journal of Medicine

2014

5.3K

Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis

Sandra P. D’Angelo, James Larkin, Jeffrey A. Sosman,

Journal of Clinical Oncology

2017

617

Survival Outcomes in Patients With Previously Untreated <i>BRAF</i> Wild-Type Advanced Melanoma Treated With Nivolumab Therapy

Paolo A. Ascierto, Georgina V. Long, Caroline Robert,

JAMA Oncology

2018

330

Five-Year Outcomes With Nivolumab in Patients With Wild-Type <i>BRAF</i> Advanced Melanoma

Caroline Robert, Georgina V. Long, Benjamin Brady,

Journal of Clinical Oncology

2020

208

Circulating Tumor DNA Analysis and Functional Imaging Provide Complementary Approaches for Comprehensive Disease Monitoring in Metastatic Melanoma

Stephen Q. Wong, Jeanette Raleigh, Jason Callahan,

JCO Precision Oncology

2017

109

Rheumatic immune-related adverse events secondary to anti–programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series

Emma L. Mitchell, Peter K. H. Lau, Chloe Khoo,

European Journal of Cancer

2018

91

A randomized, double-blind, placebo-controlled study of high-dose bosentan in patients with stage IV metastatic melanoma receiving first-line dacarbazine chemotherapy

Richard Kefford, Philip R. Clingan, Benjamin Brady,

Molecular Cancer

2010

54

Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma

Georgina V. Long, Victoria Atkinson, Paolo A. Ascierto,

Journal of Translational Medicine

2015

53

Nevi and Melanoma: Lessons from Turner’s Syndrome

Peter Gibbs, Benjamin Brady, René González,

Dermatology

2001

33

Optimizing combination dabrafenib and trametinib therapy in BRAF mutation‐positive advanced melanoma patients: Guidelines from Australian melanoma medical oncologists

Victoria Atkinson, Georgina V. Long, Alexander M. Menzies,

Asia-Pacific Journal of Clinical Oncology

2016

32

Page 1